A two-part study to evaluate safety, tolerability, and pharmacokinetics of single escalating oral doses of GSK945237 and the effect of food on single oral doses of GSK945237 in healthy adult subjects.
Phase of Trial: Phase I
Latest Information Update: 16 Mar 2012
At a glance
- Drugs GSK 945237 (Primary)
- Indications Bacterial infections
- Focus Adverse reactions
- 13 May 2011 Status changed from suspended to completed as reported by ClinicalTrials.gov.
- 12 Oct 2008 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 28 Aug 2007 New trial record.